Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingyuan Tang

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Risk Analysis : an Official Publication of the Society for Risk Analysis|February 9, 2026
Multidimensional Flood Risk Analysis of High-Speed Rail Systems Under Future Climate ChangeBingsheng Liu, Hengliang Wu, Jingyuan Tang, et al.
Journal of Cancer|February 13, 2020
LncRNA00518 promotes cell proliferation through regulating miR-101 in bladder cancerKunpeng Wang, Long Ma, Jingyuan Tang, et al.
International Journal of Clinical and Experimental Medicine|February 18, 2016
The association between rs9642880 gene polymorphism and bladder cancer risk: a meta-analysisJingyuan Tang, Xiao Li, Xuping Jiang, et al.
Experimental and Therapeutic Medicine|September 16, 2017
Preclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinomaChengkuan Cai, Jingyuan Tang, Baixin Shen, et al.
Oncotarget|September 17, 2017
Lack of association between NAT2 polymorphism and prostate cancer risk: a meta-analysis and trial sequential analysisFeng Wang, Zhiqiang Qin, Shuhui Si, et al.
Journal of Biochemical and Molecular Toxicology|June 10, 2023
Ursolic acid-downregulated long noncoding RNA ASMTL-AS1 inhibits renal cell carcinoma growth via binding to HuR and reducing vascular endothelial growth factor expressionChengkuan Cai, Yunlai Zhi, Cheng Xie, et al.
Medicine|September 16, 2016
The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysisYajie Yu, Xiao Li, Chao Liang, et al.
Oncotargets and Therapy|September 24, 2016
Association between insulin-like growth factor-binding protein-3 polymorphism-202 A/C and the risk of prostate cancer: a meta-analysisZhiqiang Qin, Xiao Li, Jingyuan Tang, et al.
Combinatorial Chemistry & High Throughput Screening|March 20, 2024
The Role of Emodin in the Treatment of Bladder Cancer Based on Network Pharmacology and Experimental VerificationFule Liu, Jianghao Li, Boruo Zhou, et al.
Journal of Cellular and Molecular Medicine|August 21, 2021
Exogenous H<sub>2</sub> S prevents the nuclear translocation of PDC-E1 and inhibits vascular smooth muscle cell proliferation in the diabetic stateLinxue Zhang, Xiaoshu Jiang, Ning Liu, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Risk Analysis : an Official Publication of the Society for Risk Analysis|February 9, 2026
Multidimensional Flood Risk Analysis of High-Speed Rail Systems Under Future Climate ChangeBingsheng Liu, Hengliang Wu, Jingyuan Tang, et al.
Journal of Cancer|February 13, 2020
LncRNA00518 promotes cell proliferation through regulating miR-101 in bladder cancerKunpeng Wang, Long Ma, Jingyuan Tang, et al.
International Journal of Clinical and Experimental Medicine|February 18, 2016
The association between rs9642880 gene polymorphism and bladder cancer risk: a meta-analysisJingyuan Tang, Xiao Li, Xuping Jiang, et al.
Experimental and Therapeutic Medicine|September 16, 2017
Preclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinomaChengkuan Cai, Jingyuan Tang, Baixin Shen, et al.
Oncotarget|September 17, 2017
Lack of association between NAT2 polymorphism and prostate cancer risk: a meta-analysis and trial sequential analysisFeng Wang, Zhiqiang Qin, Shuhui Si, et al.
Journal of Biochemical and Molecular Toxicology|June 10, 2023
Ursolic acid-downregulated long noncoding RNA ASMTL-AS1 inhibits renal cell carcinoma growth via binding to HuR and reducing vascular endothelial growth factor expressionChengkuan Cai, Yunlai Zhi, Cheng Xie, et al.
Medicine|September 16, 2016
The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysisYajie Yu, Xiao Li, Chao Liang, et al.
Oncotargets and Therapy|September 24, 2016
Association between insulin-like growth factor-binding protein-3 polymorphism-202 A/C and the risk of prostate cancer: a meta-analysisZhiqiang Qin, Xiao Li, Jingyuan Tang, et al.
Combinatorial Chemistry & High Throughput Screening|March 20, 2024
The Role of Emodin in the Treatment of Bladder Cancer Based on Network Pharmacology and Experimental VerificationFule Liu, Jianghao Li, Boruo Zhou, et al.
Journal of Cellular and Molecular Medicine|August 21, 2021
Exogenous H<sub>2</sub> S prevents the nuclear translocation of PDC-E1 and inhibits vascular smooth muscle cell proliferation in the diabetic stateLinxue Zhang, Xiaoshu Jiang, Ning Liu, et al.
Pageof 5